Clicky

Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B(BDXB)

Description: Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.


Keywords: Medicine Cancer Infectious Diseases Medical Technology Medical Device Diagnostic Products Urology Laboratory Equipment Healthcare Institutions Medical Technologies Specialty Healthcare Delivery Reagent Systems

Home Page: www.bd.com

BDXB Technical Analysis

1 Becton Drive
Franklin Lakes, NJ 07417-1880
United States
Phone: 201 847 6800


Officers

Name Title
Mr. Thomas E. Polen Jr. Pres, CEO & Chairman
Mr. Christopher DelOrefice Exec. VP & CFO
Mr. Samrat S. Khichi Esq. Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel
Mr. Thomas J. Spoerel Sr. VP, Controller & Chief Accounting Officer
Ms. Elizabeth McCombs Exec. VP & Chief Technology Officer
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Ms. Denise Fleming Exec. VP of Technology & Global Services and Chief Information Officer
Ms. Francesca M. DeMartino Sr. VP & Head of Investor Relations
Michelle Quinn Sr. VP and Chief Ethics & Compliance Officer
Troy Kirkpatrick VP of PR

Exchange: NYSE

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 7.6034
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0
IPO Date: 2020-05-21
Fiscal Year End: September
Full Time Employees: 77000
Back to stocks